AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia
Investment will triple local employment and strengthen regional pharma industry
Furthers SK Group’s plans to invest in and grow U.S. businesses
PETERSBURG, Va., May 4, 2021
AMPAC Fine Chemicals (AFC), an SK pharmteco company, is creating more than 150 new jobs and investing more than $25 million in its Petersburg, Va., site as part of a commitment to bring high-quality pharmaceutical manufacturing to the U.S.
In addition to the new jobs, AFC will expand the site’s capabilities by adding an East Coast presence for AMPAC Analytical Labs and enhanced R&D functions for continuous processing of pharmaceutical ingredients. AMPAC Analytical provides extensive development and testing services for the analysis, validation and release of intermediates and APIs.
Through the expansion, AFC will work alongside Phlow Corporation, Civica Inc. and Virginia Commonwealth University’s Medicines for All Institute to produce essential medicines for U.S. healthcare providers. AFC will make the active pharmaceutical ingredients in these medicines.
“High-quality pharmaceutical development and manufacturing are vital to meeting healthcare needs in the U.S.,” said Jeff Butler, President of AMPAC Fine Chemicals. “AFC’s Petersburg expansion will create new jobs for the region, new capabilities for Virginia’s growing pharmaceutical industry and new resources to strengthen the U.S. medical supply chain.”
Virginia Governor Ralph Northam announced the new jobs today at the Petersburg site along with other business and government partners, including Petersburg Mayor Samuel Parham.
“AMPAC’s investment will further advance the pharmaceutical cluster that has emerged in Petersburg and solidify our Commonwealth as a significant player in domestic drug manufacturing,” said Governor Northam. “This critical partnership between Phlow Corporation, Medicines for All Institute, Civica Inc., and AMPAC will have a positive and far-reaching impact, ensuring greater access to high-quality, lifesaving medications while also creating much-needed jobs to support our economic recovery in Virginia.”
